4 | SEC Filings Hub

Filing metadata

Accession number: 0001104659-21-001030
Form type: Form 4
Filer: Nabriva Therapeutics plc
CIK: CIK 1641640
Filed: Jan 05, 2021
Reporting period: Dec 31, 2020
Description: Insider transaction

Documents

0001104659-21-001030-index.htm

Complete submission

0001104659-21-001030.txt

directory listing

Filed by

Nabriva Therapeutics plc